Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 50 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 65 | 2,388−6%/yr | −6%/yr | 3.31.1× | 5% | 2,460 in 2030+0.5%/yr |
| Lumbar fusion | 65 | 2,274−3.7%/yr | −3.7%/yr | 3.11.2× | 0% | 2,210 in 2030−0.5%/yr |
| Kyphoplasty & vertebroplasty | 13 | 1,180−9.3%/yr | −9.3%/yr | 1.61.2× | 19% | 1,300 in 2030+1.7%/yr |
| Cervical fusion & disc arthroplasty | 21 | 997−4.8%/yr | −4.8%/yr | 1.41.0× | 3% | 960 in 2030−0.6%/yr |
| SI joint fusion | 3 | 192+9%/yr | +9%/yr | 0.21.2× | 27% | 430 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 343 | 70,8340%/yr | 0%/yr | 96.11.2× | 30% | 77,200 in 2030+1.4%/yr |
| Skin substitutes & wound grafts | 43 | 11,035+8.2%/yr | +8.2%/yr | 9.81.3× | 38% | 11,900 in 2030+1.2%/yr |
| Bone graft & orthobiologics | 13 | 404−19%/yr | −19%/yr | 0.60.8× | 0% | 330 in 2030−3.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 117 | 6,614−1.7%/yr | −1.7%/yr | 9.01.0× | 71% | 8,050 in 2030+3.3%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 16 | 1,1110%/yr | 0%/yr | 1.51.4× | 70% | 1,390 in 2030+3.8%/yr |
| Spinal cord & DRG stimulation | 21 | 707−4.8%/yr | −4.8%/yr | 0.91.4× | 75% | 780 in 2030+1.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 35 | 3,475−14%/yr | −14%/yr | 5.11.1× | 60% | 2,970 in 2030−2.6%/yr |
| Peripheral arterial intervention | 18 | 2,941−9.6%/yr | −9.6%/yr | 4.01.0× | 16% | 2,980 in 2030+0.2%/yr |
| Superficial venous ablation | 29 | 2,244−3.2%/yr | −3.2%/yr | 3.00.9× | 86% | 2,540 in 2030+2.1%/yr |
| Thrombectomy, IVC filters & venous stents | 7 | 1,264+6.5%/yr | +6.5%/yr | 1.81.3× | 15% | 1,940 in 2030+7.4%/yr |
| Carotid revascularization | 20 | 960−7.3%/yr | −7.3%/yr | 1.31.2× | 0% | 930 in 2030−0.5%/yr |
| Aortic endografts (EVAR/TEVAR) | 4 | 350−7.1%/yr | −7.1%/yr | 0.51.1× | 0% | 380 in 2030+1.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 39 | 4,058−4.6%/yr | −4.6%/yr | 6.11.0× | 11% | 4,490 in 2030+1.7%/yr |
| Cholecystectomy & appendectomy | 69 | 3,309−4.8%/yr | −4.8%/yr | 4.81.1× | 5% | 3,260 in 2030−0.3%/yr |
| Colorectal resection | 3 | 1,174−6.4%/yr | −6.4%/yr | 1.71.0× | 0% | 1,190 in 2030+0.2%/yr |
| Antireflux & hiatal hernia surgery | 9 | 580−0.9%/yr | −0.9%/yr | 0.81.1× | 0% | 630 in 2030+1.3%/yr |
| Breast reconstruction | 0 | 272−5%/yr | −5%/yr | 0.40.9× | 23% | 190 in 2030−6.1%/yr |
| Bariatric surgery | 0 | 105−16%/yr | −16%/yr | 0.10.7× | 0% | 90 in 2030−1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 105 | 5,228−0.5%/yr | −0.5%/yr | 7.51.4× | 11% | 6,130 in 2030+2.7%/yr |
| BPH procedures | 54 | 3,762−4.3%/yr | −4.3%/yr | 5.31.2× | 17% | 3,750 in 20300%/yr |
| Hysterectomy, hysteroscopy & ablation | 18 | 2,015−2.6%/yr | −2.6%/yr | 3.11.0× | 13% | 2,050 in 2030+0.2%/yr |
| Incontinence, prolapse & sacral neuromodulation | 18 | 1,755−4.5%/yr | −4.5%/yr | 2.51.1× | 16% | 1,650 in 2030−1%/yr |
| Prostatectomy & nephrectomy | 17 | 989+0.3%/yr | +0.3%/yr | 1.51.1× | 0% | 1,570 in 2030+8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 33 | 2,791−11%/yr | −11%/yr | 4.01.1× | 88% | 2,910 in 2030+0.7%/yr |
| Ear tubes & middle ear surgery | 10 | 483−5.4%/yr | −5.4%/yr | 0.72.3× | 52% | 490 in 2030+0.1%/yr |
| Sleep apnea & airway implants | 3 | 142+50%/yr | +50%/yr | 0.20.9× | 9% | 190 in 2030+4.8%/yr |
| Cochlear implants | 3 | 115+1.3%/yr | +1.3%/yr | 0.20.9× | 38% | 100 in 2030−1.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 62 | 4,663−4%/yr | −4%/yr | 7.01.0× | 15% | 4,600 in 2030−0.2%/yr |
| Tumor & fibroid embolization | 5 | 282+1.3%/yr | +1.3%/yr | 0.40.8× | 61% | 580 in 2030+13%/yr |
| Tumor ablation | 0 | 141+2.6%/yr | +2.6%/yr | 0.20.6× | 0% | 190 in 2030+5.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 163 | 22,848+22%/yr | +22%/yr | 31.91.2× | 89% | 37,600 in 2030+8.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 79 | 4,130−1.9%/yr | −1.9%/yr | 6.11.2× | 0% | 4,280 in 2030+0.6%/yr |
| EP ablation | 62 | 3,095+8.8%/yr | +8.8%/yr | 3.71.2× | 0% | 5,760 in 2030+11%/yr |
| LAA occlusion & loop recorders | 68 | 2,697+18%/yr | +18%/yr | 3.31.1× | 0% | 4,650 in 2030+9.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 142 | 5,468−7.3%/yr | −7.3%/yr | 6.41.1× | 0% | 5,370 in 2030−0.3%/yr |
| Structural heart (TAVR, TEER) | 68 | 1,501+7.4%/yr | +7.4%/yr | 1.81.0× | 0% | 2,410 in 2030+8.2%/yr |
| Mechanical circulatory support | 0 | 434−5.5%/yr | −5.5%/yr | 0.61.0× | 0% | 370 in 2030−2.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 10 | 254+3.3%/yr | +3.3%/yr | 0.40.9× | 0% | 320 in 2030+3.7%/yr |
| Aneurysm & intracranial embolization | 8 | 202+15%/yr | +15%/yr | 0.30.7× | 0% | 430 in 2030+13%/yr |
| DBS & VNS | 2 | 163−10%/yr | −10%/yr | 0.20.6× | 0% | 320 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 139 | 45,606−2.5%/yr | −2.5%/yr | 63.60.9× | 83% | 44,900 in 2030−0.3%/yr |
| Vitreoretinal surgery | 24 | 1,476−4.2%/yr | −4.2%/yr | 2.10.9× | 74% | 1,530 in 2030+0.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 415 | 79,616−4.3%/yr | −4.3%/yr | 117.31.0× | 30% | 80,600 in 2030+0.2%/yr |
| Bronchoscopy & lung nodule | 44 | 2,775+5.4%/yr | +5.4%/yr | 4.01.1× | 0% | 4,650 in 2030+9%/yr |
| ERCP & endoscopic ultrasound | 42 | 2,562−1%/yr | −1%/yr | 3.70.9× | 3% | 3,260 in 2030+4.1%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.